Postischemic hypoperfusion in transient global ischemia: a role for endothelins?

Area of Science:

• Neuroscience
• Cardiovascular Research
• Pharmacology

Background:

• Endothelins (ETs) are potent vasoactive peptides implicated in various physiological and pathological processes.
• Their role in regulating cerebral blood flow (CBF) following ischemic events remains incompletely understood.
• Investigating endogenous ETs' contribution to postischemic hypoperfusion is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To elucidate the role of endogenous endothelins in mediating postischemic hypoperfusion.
• To evaluate the efficacy of a broad-spectrum endothelin receptor antagonist (bosentan) in mitigating cerebral blood flow reduction after transient global ischemia.

Main Methods:

• Transient global ischemia was induced in halothane-anesthetized rats via bilateral common carotid artery occlusion and hemorrhagic hypotension.
• Postischemic hypoperfusion was assessed using hydrogen clearance in the caudate nucleus and parietal cortex.
• Cerebral blood flow was further measured using [14C]iodoantipyrine autoradiography across 35 brain regions.

Main Results:

• Bosentan pretreatment (17 mumol/kg) exhibited minimal effect on postischemic hypoperfusion over 3 hours.
• No significant alterations in CBF were observed in cortical regions or across 35 brain regions following bosentan treatment.
• Hydrogen clearance measurements also indicated no substantial changes in CBF after the ischemic insult.

Conclusions:

• Endogenous endothelins do not appear to play a major role in mediating postischemic hypoperfusion in this rat model.
• Broad-spectrum endothelin receptor antagonism with bosentan is ineffective in improving cerebral blood flow recovery after transient global ischemia.